BioSpace News Archive

Pharm Country

ANSYS 2019 R1 Delivers Speed and Ease of Use for Engineers Solving Next-Generation Product Challenges

ANSYS Pervasive Engineering Simulation solutions empower companies across industries to retain engineers

January 29, 2019
·
10 min read
Policy

AudioCure Pharma’s AC102 receives EMA orphan drug designation for the treatment of sudden sensorineural hearing loss (SSNHL)

The EMA’s Committee for Orphan Medicinal Products has granted orphan drug designation to AC102, concluding that AudioCure’s lead compound may be of significant benefit for patients suffering with the rare and chronically debilitating disease of sudden sensorineural hearing loss (SSNHL).

January 29, 2019
·
2 min read
Job Trends

Triumvira Immunologics to Present at CAR-T Congress EU in London, UK

Triumvira Immunologics today announced that Dr. Paul Lammers, President & CEO, will both present and moderate a round table discussion at the CAR-T Congress EU, to be held in London UK on January 30-31.

January 29, 2019
·
2 min read
Genetown

Lyndra Therapeutics Raises $55 Million in Series B Financing

Lyndra Therapeutics today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, expansion of its Phase I pipeline and manufacturing scale-up.

January 29, 2019
·
3 min read
Deals

Premier Health Announces Closing of Cloud Practice Inc. Acquisition

Cloud Practice Inc., a medical software application company with products including: Juno EMR, a cloud-based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal

January 29, 2019
·
5 min read
Business

Neptune to Hold Conference Call to Discuss Third Quarter Results for the Three Months Period Ended December 31, 2018

Neptune Wellness Solutions Inc. announces that it will be holding a conference call on February 13, 2019 at 5:00 PM (EST) to discuss its third quarter results for the three months period ended December 31, 2018.

January 29, 2019
·
1 min read
Business

Invitae to announce fourth quarter and year-end 2018 financial results on February 19, 2019

Invitae Corporation today announced that it will report its fourth quarter and year-end 2018 financial results on Tuesday, February 19, 2019 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent developments.

January 29, 2019
·
1 min read
Drug Development

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

Successfully completed all Phase 1 requirements of TIARA-II

January 29, 2019
·
9 min read
Policy

Cultivation License Secured for TGOD’s Operations in Denmark

The Green Organic Dutchman Holdings Ltd. is pleased to announce that the Danish Medicines Agency, the Government body responsible for issuing cannabis related licenses, has granted an initial cannabis business authorization to TGOD’s joint venture production partner Knud Jepsen.

January 29, 2019
·
5 min read
Policy

Nutriband Inc. Granted Prioritized Examination from the United States Patent and Trademark Office for Abuse Deterrent Technology Patent Application

Nutriband Inc. announced today that the United States Patent and Trademark Office (“USPTO”) has granted the Company’s request for Prioritized Examination (Track One) of the U.S. patent application for “Abuse and Misuse Deterrent Transdermal System” submitted by its subsidiary, 4P Therapeutics LLC.

January 29, 2019
·
4 min read